- Home
- QNCX vs KLXE Comparison
QNCX vs KLXE Comparison
Compare QNCX & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- KLXE
- Stock Information
- Founded
- QNCX 2012
- KLXE 2018
- Country
- QNCX United States
- KLXE United States
- Employees
- QNCX N/A
- KLXE N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- KLXE Oilfield Services/Equipment
- Sector
- QNCX Health Care
- KLXE Energy
- Exchange
- QNCX Nasdaq
- KLXE Nasdaq
- Market Cap
- QNCX 47.7M
- KLXE 35.8M
- IPO Year
- QNCX 2019
- KLXE N/A
- Fundamental
- Price
- QNCX $1.61
- KLXE $1.95
- Analyst Decision
- QNCX Strong Buy
- KLXE Hold
- Analyst Count
- QNCX 5
- KLXE 1
- Target Price
- QNCX $8.00
- KLXE $4.50
- AVG Volume (30 Days)
- QNCX 352.5K
- KLXE 289.9K
- Earning Date
- QNCX 08-12-2025
- KLXE 08-06-2025
- Dividend Yield
- QNCX N/A
- KLXE N/A
- EPS Growth
- QNCX N/A
- KLXE N/A
- EPS
- QNCX N/A
- KLXE N/A
- Revenue
- QNCX N/A
- KLXE $688,600,000.00
- Revenue This Year
- QNCX N/A
- KLXE N/A
- Revenue Next Year
- QNCX N/A
- KLXE $3.97
- P/E Ratio
- QNCX N/A
- KLXE N/A
- Revenue Growth
- QNCX N/A
- KLXE N/A
- 52 Week Low
- QNCX $0.51
- KLXE $1.51
- 52 Week High
- QNCX $2.45
- KLXE $7.66
- Technical
- Relative Strength Index (RSI)
- QNCX 64.95
- KLXE 49.01
- Support Level
- QNCX $1.48
- KLXE $1.84
- Resistance Level
- QNCX $1.68
- KLXE $2.06
- Average True Range (ATR)
- QNCX 0.14
- KLXE 0.29
- MACD
- QNCX 0.02
- KLXE -0.03
- Stochastic Oscillator
- QNCX 85.71
- KLXE 19.83
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.